|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$592,373
|
N/A
|
(NCI)
|
|
SPARC as a regulator of collagen signaling in Pancreatic Cancer
|
1F31CA168350-01
|
$29,597
|
$29,597
|
Aguilera, Kristina
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
$72,557
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$152,996
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$5,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$10,069
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$276,767
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
MCM Helicase as a Novel Target for Pancreatic Cancer Treatment
|
5R21CA155393-02
|
$181,613
|
$181,613
|
Alexandrow, Mark
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-04
|
$552,746
|
$276,373
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer
|
1R21CA167122-01
|
$236,749
|
$236,749
|
Allen, Benjamin
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Antibody bead array technology for diagnosis of pre-invasive pancreatic cancer
|
5R21CA158267-02
|
$238,685
|
$238,685
|
Allen, Peter
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,264,778
|
$63,239
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
$1,276
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
$25,167
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-05
|
$350,890
|
$115,794
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$40,328
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
LTG_Amundadottir
|
ZIA CP010201-10569
|
$601,906
|
$421,334
|
Amundadottir, Laufey
|
DCEG (NCI)
|
|
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer
|
1R21CA164593-01
|
$212,556
|
$212,556
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Molecular Basis for Localization and Activation of Focal Adhesion Kinase
|
1R03CA169969-01
|
$79,000
|
$79,000
|
Arold, Stefan
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio
|
1R21CA169673-01
|
$172,957
|
$172,957
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIABC010997
|
$51,632
|
$15,490
|
Avital, Itzhak
|
CCR (NCI)
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIABC011003
|
$103,265
|
$30,979
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIABC011004
|
$154,897
|
$30,979
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Approaches
|
ZIABC011005
|
$103,265
|
$10,326
|
Avital, Itzhak
|
CCR (NCI)
|
|
Pancreatic perfusion for locally unresectable pancreatic cancer
|
ZIABC011342
|
$51,632
|
$51,632
|
Avital, Itzhak
|
CCR (NCI)
|
|
TGF-Beta signaling and microRNA processing: Implications for invasion and metasta
|
5F31CA142238-04
|
$36,179
|
$36,179
|
Azevedo, Ana Clara
|
OHIO STATE UNIVERSITY
|
|
Mechanistic Studies of MUC4 and NGAL in Pancreatic Adenocarcinoma
|
1F31CA165885-01
|
$26,688
|
$26,688
|
Baine, Michael
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Mechanisms of Signal Transduction by Ras Proteins
|
5R01CA055360-21
|
$409,825
|
$409,825
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
|
ZIABC010451
|
$306,950
|
$153,475
|
Barchi, Joseph
|
CCR (NCI)
|
|
TGF-beta Signaling in Pancreatic Cancer
|
5R01CA133557-05
|
$346,958
|
$346,958
|
BARDEESY, NABEEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples
|
5R21CA137687-03
|
$235,448
|
$235,448
|
Barrett, Michael
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIABC010622
|
$226,824
|
$22,682
|
Bates, Susan
|
CCR (NCI)
|
|
Targeting MUC4 for chemosensitization of pancreatic cancer
|
1R03CA167342-01A1
|
$73,571
|
$73,571
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Molecular Markers for the Diagnosis of Pancreatic Cancer
|
5R01CA131944-05
|
$297,686
|
$297,686
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Smoking and pancreatic cancer
|
5R01CA133774-05
|
$307,952
|
$307,952
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Pancreatic Tumor Micro-environment Network
|
5U54CA163120-02
|
$818,351
|
$818,351
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
LRH-1: Structure-based Approach to Drug Design for Gastrointestinal Tumors
|
1F32CA163092-01A1
|
$59,432
|
$20,207
|
Bayrer, James
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Simultaneous attack of epithelial and stromal compartments in pancreatic cancer
|
1R21CA158640-01A1
|
$217,546
|
$217,546
|
BEACHY, PHILIP
|
STANFORD UNIVERSITY
|
|
CD40 Pathway in Pancreatic Adenocarcinoma
|
5K08CA138907-02
|
$162,462
|
$162,462
|
Beatty, Gregory
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
$3,000
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
$58,180
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Surgical Oncology Research Training
|
5T32CA106493-08
|
$45,805
|
$11,451
|
BEHRNS, KEVIN
|
UNIVERSITY OF FLORIDA
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$334,937
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,697
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$2,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S1
|
$50,000
|
$4,500
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S2
|
$75,000
|
$6,750
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-30
|
$2,547,570
|
$229,281
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Enhancing tumor vascular damage with gold nanoparticles aided radiation therapy
|
1R03CA164645-01A1
|
$84,903
|
$84,903
|
Berbeco, Ross
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Pancreas for this search: $105,352,789
|